Recommended Pages at packaging.pharmaceutical-business-review.com
Cephalon Gabitril REMS gets FDA approval - Pharmaceutical Business Review
packaging.pharmaceutical-business-review.com — “Cephalon said that a Risk Evaluation and Mitigation Strategy (REMS) for its antiepileptic medication Gabitril (tiagabine hydrochloride) has been appro” View full resource at packaging.pharmaceutical-business-review.com
Most Recently Shared on October 15, 2010 at 6:49 am By:
Cephalon Gabitril REMS gets FDA approval http://goo.gl/bMIE #pharmaceutical #news
